FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205123661> ?p ?o ?g. }

• W4205123661 endingPage "314" @default.
• W4205123661 startingPage "309" @default.
• W4205123661 abstract "Sarcopenia is defined as a combination of low muscle mass with low muscle function. The term was first used to designate the loss of muscle mass and performance associated with aging. Now, recognized causes of sarcopenia also include chronic disease, a physically inactive lifestyle, loss of mobility, and malnutrition. Sarcopenia should be differentiated from cachexia, which is characterized not only by low muscle mass but also by weight loss and anorexia. Sarcopenia results from complex and interdependent pathophysiological mechanisms that include aging, physical inactivity, neuromuscular compromise, resistance to postprandial anabolism, insulin resistance, lipotoxicity, endocrine factors, oxidative stress, mitochondrial dysfunction, and inflammation. The prevalence of sarcopenia ranges from 3% to 24% depending on the diagnostic criteria used and increases with age. Among patients with rheumatoid arthritis 20% to 30% have sarcopenia, which correlates with disease severity. Sarcopenia exacts a heavy toll of functional impairment, metabolic disorders, morbidity, mortality, and healthcare costs. Thus, the consequences of sarcopenia include disability, quality of life impairments, falls, osteoporosis, dyslipidemia, an increased cardiovascular risk, metabolic syndrome, and immunosuppression. The adverse effects of sarcopenia are particularly great in patients with a high fat mass, a condition known as sarcopenic obesity. The diagnosis of sarcopenia rests on muscle mass measurements and on functional tests that evaluate either muscle strength or physical performance (walking, balance). No specific biomarkers have been identified to date. The management of sarcopenia requires a multimodal approach combining a sufficient intake of high-quality protein and fatty acids, physical exercise, and antiinflammatory medications. Selective androgen receptor modulators and anti-myostatin antibodies are being evaluated as potential stimulators of muscle anabolism." @default.
• W4205123661 created "2022-01-26" @default.
• W4205123661 creator A5061070284 @default.
• W4205123661 creator A5062958039 @default.
• W4205123661 creator A5078788580 @default.
• W4205123661 creator A5081382880 @default.
• W4205123661 creator A5090403305 @default.
• W4205123661 date "2019-05-01" @default.
• W4205123661 modified "2023-10-16" @default.
• W4205123661 title "Sarcopenia" @default.
• W4205123661 cites W1538971878 @default.
• W4205123661 cites W1597681260 @default.
• W4205123661 cites W1747496722 @default.
• W4205123661 cites W1851301093 @default.
• W4205123661 cites W1867779249 @default.
• W4205123661 cites W1917806107 @default.
• W4205123661 cites W1966105667 @default.
• W4205123661 cites W1983648870 @default.
• W4205123661 cites W2003877413 @default.
• W4205123661 cites W2005945151 @default.
• W4205123661 cites W2020213864 @default.
• W4205123661 cites W2029230411 @default.
• W4205123661 cites W2031663686 @default.
• W4205123661 cites W2037048755 @default.
• W4205123661 cites W2041979286 @default.
• W4205123661 cites W2043300911 @default.
• W4205123661 cites W2044351326 @default.
• W4205123661 cites W2051446390 @default.
• W4205123661 cites W2053533379 @default.
• W4205123661 cites W2055581629 @default.
• W4205123661 cites W2058352001 @default.
• W4205123661 cites W2058368576 @default.
• W4205123661 cites W2059103338 @default.
• W4205123661 cites W2060757943 @default.
• W4205123661 cites W2063690006 @default.
• W4205123661 cites W2086518239 @default.
• W4205123661 cites W2096423991 @default.
• W4205123661 cites W2099281324 @default.
• W4205123661 cites W2102902846 @default.
• W4205123661 cites W2116294028 @default.
• W4205123661 cites W2118558111 @default.
• W4205123661 cites W2124028388 @default.
• W4205123661 cites W2134990859 @default.
• W4205123661 cites W2135281138 @default.
• W4205123661 cites W2142421300 @default.
• W4205123661 cites W2150979246 @default.
• W4205123661 cites W2155877918 @default.
• W4205123661 cites W2156791190 @default.
• W4205123661 cites W2159296038 @default.
• W4205123661 cites W2160777768 @default.
• W4205123661 cites W2162274253 @default.
• W4205123661 cites W2166295622 @default.
• W4205123661 cites W2170351370 @default.
• W4205123661 cites W2189509884 @default.
• W4205123661 cites W2212214767 @default.
• W4205123661 cites W2337136485 @default.
• W4205123661 cites W2340399078 @default.
• W4205123661 cites W2411932037 @default.
• W4205123661 cites W2478127453 @default.
• W4205123661 cites W2531701661 @default.
• W4205123661 cites W2579442275 @default.
• W4205123661 cites W2587593559 @default.
• W4205123661 cites W2589128612 @default.
• W4205123661 cites W2597303623 @default.
• W4205123661 cites W2604779860 @default.
• W4205123661 cites W2756859424 @default.
• W4205123661 cites W2765246109 @default.
• W4205123661 cites W2772563911 @default.
• W4205123661 doi "https://doi.org/10.1016/j.jbspin.2018.08.001" @default.
• W4205123661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30098424" @default.
• W4205123661 hasPublicationYear "2019" @default.
• W4205123661 type Work @default.
• W4205123661 citedByCount "170" @default.
• W4205123661 countsByYear W42051236612019 @default.
• W4205123661 countsByYear W42051236612020 @default.
• W4205123661 countsByYear W42051236612021 @default.
• W4205123661 countsByYear W42051236612022 @default.
• W4205123661 countsByYear W42051236612023 @default.
• W4205123661 crossrefType "journal-article" @default.
• W4205123661 hasAuthorship W4205123661A5061070284 @default.
• W4205123661 hasAuthorship W4205123661A5062958039 @default.
• W4205123661 hasAuthorship W4205123661A5078788580 @default.
• W4205123661 hasAuthorship W4205123661A5081382880 @default.
• W4205123661 hasAuthorship W4205123661A5090403305 @default.
• W4205123661 hasBestOaLocation W42051236611 @default.
• W4205123661 hasConcept C126322002 @default.
• W4205123661 hasConcept C2776214593 @default.
• W4205123661 hasConcept C2776541429 @default.
• W4205123661 hasConcept C2777328239 @default.
• W4205123661 hasConcept C71924100 @default.
• W4205123661 hasConceptScore W4205123661C126322002 @default.
• W4205123661 hasConceptScore W4205123661C2776214593 @default.
• W4205123661 hasConceptScore W4205123661C2776541429 @default.
• W4205123661 hasConceptScore W4205123661C2777328239 @default.
• W4205123661 hasConceptScore W4205123661C71924100 @default.
• W4205123661 hasIssue "3" @default.
• W4205123661 hasLocation W42051236611 @default.
• W4205123661 hasLocation W42051236612 @default.

• next